Educational Lecture

To get the latest update, please clear or refresh your web browser's cache.
*i.e. Google Chrome: Ctr + F5 keys

Program at a Glance

Educational Lecture

Lecture language E = English J = Japanese
( = Simultaneous Interpretation service is available.)

Monday, September 25

Topic1:Expanding the Role of LC-MS/MS in Therapeutic Drug Monitoring (TDM)
Topic2:TDM by LC/MS-Single analyte, multiplexing and novel drugs

Chair: Jose Castro-Perez, USA

Speakers:

EL-1-1: Yusuke Tanigawara (Keio University School of Medicine, Japan)

EL-1-2: Gareth Hammond (Waters Corporation, UK)

Modern targeted and untargeted LC-MS/MS screenings, and automated sample preparation system

1. Clinical Laboratory Innovation by LC-MS/MS
2. Modern targeted and untargeted LC-MS/MS screenings using low resolution systems

Chair: Akira Ishii, Japan

Speakers:

EL-2-1: Hikaru Shibata (Shimadzu Corporation, Japan)

EL-2-2: Franck Saint-Marcoux (Limoges University Hospital, France)

State of the Art Immunosuppressant Methodologies and Clinical Considerations

Chair: Moe Kawai, Japan

Speaker:: Randal Schneider (Abbott Laboratories, USA)

Implementation of the Toxtyper LC-MSⁿ instrument in a routine laboratory for drug of abuse screening in urine

Chair: Markus Meyer, Germany

Speaker:: Eberhard Wieland (Institute for Clinical Chemistry and Laboratory Medicine, Laboratory at Katharinenhospital, Germany)

Precision medicine in the lung cancer

Chair: Chiyo K. Imamura, Japan

Speaker:: Hirotsugu Kenmotsu (Shizuoka Cancer Center, Japan)

Cancer immunotherapy - from basic research to clinic

Chair: Atsushi Otsuka, Japan

Speaker:: Yuka Maeda (National Cancer Center Research Institute, Japan)

Overview of the treatment strategies for patients with melanoma; focusing on the difference between Western countries and Japan

Chair: Atsushi Otsuka, Japan

Speaker:: Kenjiro Namikawa (National Cancer Center Hospital, Japan)

Tuesday, September 26

Current status of Therapeutic Drug Monitoring of immunosuppressants

Chair: Satohiro Masuda, Japan

Speaker:: Yoshihiko Watarai (Nagoya Daini Red Cross Hospital, Japan)

Current Topics for Therapeutic Drug Monitoring of Immunosuppressive Drugs
～Pharmacokinetics, Pharmacogenetics, and TDM of Immunosuppressive Drugs～

Chair: Yoshihiko Watarai, Japan

Speaker:: Shigeru Satoh (Akita University Hospital, Japan) (Simultaneous Interpretation available)

Reinforced molecular targeted therapy for Ph+ Leukemias based on risk-benefit assessment

リスク－ベネフィットを考慮したPh陽性白血病の第3世代分子標的治療

Speaker:: Arinobu Tojo (The University of Tokyo, Japan)

Pharmacokinetics/Pharmacodynamics of Lusutrombopag, a Thrombopoietin Receptor Agonist, and Prediction of Platelet Count Profile

トロンボポエチン受容体アゴニスト・ルストロンボパグのPK/PDに基づく血小板数予測

Chair: Yoshitaka Yano, Japan

Speaker:: Toshihiro Wajima (Shionogi & Co., Ltd., Japan)

The possibility of exposure response in ramucirumab therapy

Chair: Yuichi Ando, Japan

Speaker:: Toshihiko Doi (National Cancer Center Hospital East, Japan) (Simultaneous Interpretation available)

Exposure-response of erlotinib in patients with non-small cell lung cancer

Chair: Yasutsuna Sasaki, Japan

Speaker:: Chiyo K. Imamura (Keio University School of Medicine, Japan)

The Leading Edge of Therapeutic Monoclonal Antibody Monitoring:Paradigm Shift in Protein Bioanalysis by Mass Spectrometry
1.Novel monoclonal antibody bioanalysis from SHIMADZU: nano-surface and molecular-orientation limited (nSMOL) proteolysis
2.Therapeutic drug monitoring for monoclonal antibodies

Chair: Satohiro Masuda, Japan

Speakers:

EL-14-1: Takashi Shimada (Shimadzu Corporation, Japan)

EL-14-2: Atsushi Yonezawa (Kyoto University, Japan)

Wednesday, September 27

Educational Lecture : A to Z of Tacrolimus

Chair: Kenji Yuzawa, Japan

Speakers:

EL-15-1: Satohiro Masuda (Kyushu University Hospital, Japan)

EL-15-2: Atsushi Yoshizawa (Kyoto University, Japan)

Drug of abuse crisis - interactions with therapeutics-role of clinical toxicologist

Chair: Marilyn A. Huestis, USA

Speaker:: Manuela Neuman (University of Toronto, Canada)

PK/PD modeling and simulation approach to guide effective dosing strategy for antibiotic

モデル＆シミュレーションを用いた抗菌薬のPK/PDと投与設計

Chair: Masato Homma, Japan

Speaker:: Toshimi Kimura (Tokyo Women's Medical University Hospital, Japan) (Simultaneous Interpretation available)

Automateｄ Drug Monitoring exploring new accuracy frontiers
1.TDM-Immunoassay goes LC-MS/MS
2.Drugs of abuse-Automated immunoassays for forensic drug testing?

Chair: Satohiro Masuda, Japan

Speakers:: André Richter (Roche Diagnostics International AG, Switzerland)

: Eva Hoess (Roche Diagnostics GmbH, Germany)